Pharma Kenis

Private limited companyfounded 201510 yrs activeKollegestraat 26, 2440 Geel, BelgiumKBO/BCE: BE 0644.677.737

Summary

Pharma Kenis has a registered holding activity and consists mainly of financial fixed assets; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €921,259 and a net result of €143,121. Equity is growing by ~21% per year across the filed fiscal years. Its solvency ranks better than 81% of 21069 sector peers (fiscal year 2025). The company has been active since 2015 and the Belgian State Gazette contains no insolvency or warning signals.

Risk analysisWatch Report Compare

Pharma KenisActive

Risk analysis Report Compare

Activity

Retail sale of pharmaceutical products

NACE 47730

1 site

Size

€1.3mtotal assets 2025

Equity: €921,259
Profit: €143,121

Turnover not published (abridged schema)

Financial health

Holding: outside the score modelProbability: sector outside the model

Structure

Accounts filed 26 d late0 of 4 deeds read

SignalsFiled after the deadlineShow the evidence

Checked score

Outside the general model

Holding: general score not applicable

The company has a registered holding activity and financial fixed assets account for more than half of its assets. The general operating-company model is unsuitable for this profile, so we show no financial axes either. Filed figures remain available.

Bankruptcy probability, 12 months

This is a financial institution (bank, insurer or financial holding). A bank balance sheet works differently from that of an ordinary trading or manufacturing company. We therefore show no bankruptcy probability rather than a misleading figure.

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

1 signal. The signal on the left, the evidence on the right.

○neutral

Filed after the deadline

The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 26-05-2026, 26 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.

NBB · 10 filings

Deviation from the deadline

2025

26 d late

2024

27 d late

2023

31 d late

2022

31 d late

2021

16 d late

2020

28 d late

2019

18 d late

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 25 days after the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.

Checked, nothing found (2)

The next deadline is still running

The next financial year closes on 30-09-2026 and is due by 30-04-2027. Nothing is late today. Usually files around 27 May (5 of the last 5 filed years within 30 days of that day).

Companies Code · seven months

Position in the running window

30-09-2026 close03-10-2026 today30-04-2027 deadline

No strike-offs in the KBO publications

We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

KBO publications · our coverage

26-05-26 Annual accounts filedfiscal year 2025 · micro…
27-05-25 Annual accounts filedfiscal year 2024 · micro…
30-09-24 Highest result since 2019net €163,057 ▲12.8%

Key points

Positive: Among the best 5% on net resultsector median €5,049 · 21,046 companies €143,121 View
Positive: 7 profitable years in a rowprofit 2025: €143,121 7 years View
Total assets 20256 fiscal years filed €1.3m View